ENG
- KOR
- ENG
Our cytotherapy laboratory, founded under the mission of commercialization of cell therapy products, is spurring R&D
based on the foundation of the best technological prowess and excellent research talents in the future industry of cell
therapy. We have applied/registered for multiple patents related to cytotherapy technologies, continuing to secure
intellectual properties and contributing to international academic journals, receiving overseas recognition for research
feats Using our experience in immunocyte therapy development as our foothold, we shall contribute to improving the
quality of life for humankind by devoting ourselves to next-generation cell/gene therapy products and stem cell
research toward developing various cell therapy products.
· scFV-CAR-NK
· NCR-CAR-NK
· Proprietary NK-specific co-stimulatory domains
· Used for generating proprietary CAR constructs
· 3rd generation lentivirus
· Knock-out of gene of interest
· Patent-protected mass culture system using a bioreactor
· Patent-protected e-feeder cell system for NK expansion
· Automatic process developmen
· GMP production
· Patent-protected
· Extended stability (~2 years)
· Global shipping available
· Use of FDA approved CBUs
· Easy-to-supply, Stable, and safe
· Low donor-donor variation
5 Technology strengths of GC Cell are the key building blocks for
cell and gene therapy research and development
Pharmaceutical
Healthcare
Overseas
Foundation
Others